(-0.34%) 5 018.39 points
(0.23%) 37 903 points
(-0.33%) 15 605 points
(0.47%) $79.37
(1.14%) $1.954
(0.83%) $2 330.10
(0.42%) $26.86
(1.27%) $967.00
(-0.01%) $0.933
(-0.08%) $11.02
(-0.09%) $0.798
(0.27%) $93.51
0.45% $ 4.44
@ $2.66
Wydano: 14 vas. 2024 @ 21:44
Zwrot: 66.92%
Poprzedni sygnał: vas. 14 - 20:41
Poprzedni sygnał:
Zwrot: -3.45 %
Live Chart Being Loaded With Signals
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications...
Stats | |
---|---|
Dzisiejszy wolumen | 580 765 |
Średni wolumen | 1.82M |
Kapitalizacja rynkowa | 507.23M |
EPS | $0 ( 2024-03-28 ) |
Następna data zysków | ( $-0.0700 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.13 |
ATR14 | $0.0140 (0.32%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-12 | Hooks Corwin Dale | Buy | 300 000 | Common Stock |
2024-04-12 | Hooks Corwin Dale | Buy | 0 | |
2024-03-14 | Shendelman Shoshana | Sell | 318 573 | Common Stock |
2024-03-14 | Perfetti Riccardo | Sell | 110 804 | Common Stock |
2024-03-14 | Hansard Adam | Sell | 48 871 | Common Stock |
INSIDER POWER |
---|
40.99 |
Last 97 transactions |
Buy: 24 985 894 | Sell: 4 549 161 |
Wolumen Korelacja
Applied Therapeutics Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
NISN | 0.932 |
EYPT | 0.926 |
SEAC | 0.906 |
CYCN | 0.901 |
SCR | 0.891 |
ADMP | 0.889 |
ICON | 0.889 |
WORX | 0.889 |
ACLX | 0.889 |
LEGN | 0.886 |
10 Najbardziej negatywne korelacje | |
---|---|
CHDN | -0.91 |
REYN | -0.884 |
SCOR | -0.882 |
VTRU | -0.881 |
DCRC | -0.877 |
SGLB | -0.872 |
ALGM | -0.866 |
ENLV | -0.863 |
MTEX | -0.863 |
DCGO | -0.862 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Applied Therapeutics Inc Korelacja - Waluta/Towar
Applied Therapeutics Inc Finanse
Annual | 2023 |
Przychody: | $9.99M |
Zysk brutto: | $9.64M (96.47 %) |
EPS: | $-1.420 |
FY | 2023 |
Przychody: | $9.99M |
Zysk brutto: | $9.64M (96.47 %) |
EPS: | $-1.420 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-441 000 (0.00 %) |
EPS: | $-2.16 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-4.12 |
Financial Reports:
No articles found.
Applied Therapeutics Inc
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej